ALFA Filings
Every announcement, straight from the exchange
Every Privi Speciality Chemicals earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.
Privi reported strong Q1 FY27 results with 20.01% YoY revenue growth. Strategy focuses on '5k | 1k' vision via capacity expansion and higher-value specialty molecules.
Privi reported strong FY26 performance with 22% revenue growth and 25.76% EBITDA margins, driven by volume growth and improved product mix.
Privi delivered strong FY26 performance with 22% revenue growth and 25%+ margins. Management is pivoting from a '5k revenue' goal to a more aggressive long-term trajectory via high-value specialty molecules and backward integration.